نتایج جستجو برای: chronic itp

تعداد نتایج: 499127  

Journal: :Blood 2016
Xin-Guang Liu Shuang Liu Qi Feng Xue-Na Liu Guo-Sheng Li Zi Sheng Peng Chen Yang Liu Yu Wei Xiao-Yuan Dong Ping Qin Chengjiang Gao Chunhong Ma Lei Zhang Ming Hou Jun Peng

Elevated expression of the activating Fcγ receptor (FcγR) I and FcγRIIa together with decreased expression of the inhibitory FcγRIIb are involved in the pathogenesis of primary immune thrombocytopenia (ITP). Thrombopoietin receptor agonists (TPO-RAs) have been used clinically for the management of ITP; however, little is known about the effect of TPO-RAs on FcγR modulation in ITP. In this prosp...

2017
Khan Sheema Ujjan Ikramdin Naz Arshi Naz Farah Sheikh Imran

Background. Idiopathic thrombocytopenic purpura (ITP) is a bleeding disorder in which the immune system destroys native platelets. In this condition an autoantibody is generated against a platelet antigen. ITP affects women more often than men and is more common in children than adults. Objective. To assess the effect of Helicobacter pylori eradication therapy (HPET) on platelet count in Helico...

2017
H. J. Laws G. Janssen A. Borkhardt

Approximately 70% of children have the acute form of immune thrombocytopenia (ITP), which is defined by recovery within six months of presentation with or without treatment. Chronic ITP is to be reserved for patients with platelets < 100 000/μl for more than twelve months and exclusion of other diagnosis like systemic lupus erythematosus or bone marrow failures. In children, the chance of spont...

2012
Carlo Visco Francesco Maura Giacomo Tuana Luca Agnelli Marta Lionetti Sonia Fabris Elisabetta Novella Ilaria Giaretta Gianluigi Reda Wilma Barcellini Luca Baldini Antonino Neri Francesco Rodeghiero Agostino Cortelezzi

Purpose: To assess biologic features related to the development of immune thrombocytopenia (ITP) in patients with chronic lymphocytic leukemia (CLL). Experimental Design:We retrospectively analyzed 463 patients with CLL with available immunoglobulin heavy-chain variable (IGHV) gene status and B-cell receptor (BCR) configuration [heavy-chain complementary-determining region 3 (HCDR3)], of whom t...

Journal: :Blood 1981
M J Stuart J G Kelton J B Allen

We observed several patients with chronic idiopathic thrombocytopenic purpura (ITP) whose bleeding times were more prolonged than would have been expected from their platelet counts. To investigate this further, we performed in vivo and in vitro platelet function studies, assessed arachidonate metabolism, and measured platelet-associated IgG (PAIGG) in seven patients with chronic ITP. The bleed...

Journal: :Medicine 2011
Matthieu Mahévas Laurent Chiche Yurdagul Uzunhan Medhi Khellaf Anne Sophie Morin Guillaume Le Guenno Véronique Péronne Louis Affo Olivier Lidove David Boutboul Genevieve Dion Jean-Pierre Ducroix Thomas Papo Yves Pacheco Nicolas Schleinitz Marc Michel Bertrand Godeau Dominique Valeyre

The association of sarcoidosis and immune thrombocytopenia (ITP) has rarely been investigated. The aim of the current retrospective study was to investigate the clinical and biological phenotypes and outcome of this association in a large series of recent patients. Twenty patients (50% men) were included. Median age at sarcoidosis and ITP diagnosis was 36 (range, 10-83 yr) and 38 (range, 21-83 ...

Journal: :Gut and liver 2016
Tae Ho Kim Dae Young Cheung

Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea was revised in 2013 and idiopathic thrombocytopenic purpura (ITP) was enlisted as a target for H. pylori eradication therapy with high level of evidence and strong recommendation grade. Clinical studies have steadily reported the rise of platelet count after H. pylori eradication roughly in a half of the patien...

2016
Chul Won Jung Su-Hee Cho Sylvia Park Jun Ho Jang Jun Ho Ji

Fig. 1. Platelet count after alemtuzumab treatment. Successful treatment of steroid-refractory immune thrombocytopenia with alemtuzumab TO THE EDITOR: Immune thrombocytopenia (ITP) is an immune-mediated disease characterized by an isolated decrease in platelet count. There are multiple mechanisms underlying this disease, including autoantibodies against platelet membrane proteins and impaired p...

2016
Susan D. Mathias Xiaoyan Li Melissa Eisen Nancy Carpenter Ross D. Crosby Victor S. Blanchette

BACKGROUND Chronic immune thrombocytopenia (ITP) in children can negatively impact their health-related quality of life (HRQoL) and impose a burden on their parents. This study sought to examine the effect of romiplostim on HRQoL and parental burden in children with primary ITP. PROCEDURE This was a phase 3, randomized, double-blind, placebo-controlled study. Children aged <18 years with ITP ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید